Robust bioanalysis for ADC PK and immunogenicity, as well as custom biomarker assays for every stage of drug development.

Trusted biosimilar bioanalysis with proven assays and regulatory insight to support comparability, safety, and efficacy studies.

Comprehensive biomarker analysis to support drug development, with regulatory and scientific insight across therapeutic areas.

Comprehensive fusion protein bioanalysis with regulatory expertise to support development from pre-clinical to approval.

Advanced molecular and bioanalytical techniques and scientific experts to support the most challenging gene therapy development

Expert immunotherapy bioanalysis with validated assays and regulatory support to advance innovative immune-based treatments.

Reliable ligand-binding assays for biologics, supporting PK, PD, and immunogenicity with validated, regulatory-compliant methods.

Specialized mAb bioanalysis with validated assays and deep expertise to support development, characterization, and regulatory success.

Precise nucleic acid quantification with validated methods to support gene therapy, oligo analysis, and regulatory submissions.